Although several studies have followed the course of depression throughout the lifespan, the characteristics of depression at different developmental stages haven't been clearly identified. New research published in Clinical Psychological Science, a journal of the Association for Psychological Science, presents a unique longitudinal investigation of depression across four critical developmental periods from childhood to adulthood.
To better understand the developmental course of Major Depressive Disorder (MDD), Paul Rohde of the Oregon Research Institute and colleagues analyzed data collected from individuals participating in the Oregon Adolescent Depression Project.
Using these data, the researchers were able to compare and contrast the presentation of MDD across four developmental periods: childhood (5.0-12.9 years), adolescence (13.0-17.9 years), emerging adulthood (18.0-23.9 years), and adulthood (24.0-30.0 years).
Interviewers assessed participants for symptoms of depression at each of the four time points. The participants also completed follow-up evaluations that assessed the onset and duration of all major psychiatric disorders since the previous time point.
MDD recovery was defined as 8 or more consecutive weeks of no or minor symptoms and MDD recurrence was defined as meeting full MDD criteria following recovery. Both of these definitions are in line with consensus definitions in the field.
The interviewers conducting the diagnostic assessments were carefully selected, trained, and supervised. Each one of the interviewers had a degree in a mental health discipline and had completed a 70-hour course in diagnostic interviewing.
Rohde and colleagues examined data from 816 participants who had completed the questionnaires and interviews at all four time points.
By age 30, 51% of the sample had experienced an episode of MDD. Among the participants who developed one episode of MDD, more than half (53%) had at least one recurrent MDD episode by age 30. Being female was a consistent predictor of a first incidence of MDD in all four of the developmental periods but did not significantly predict recurrence.
First incidence and recurrent episodes of MDD were lower in childhood than in adolescence, emerging adulthood, or adulthood. While MDD during childhood was infrequent, episodes that occurred in this early developmental period lasted significantly longer than those episodes that occurred in the subsequent three periods. As the researchers expected, having an episode in one developmental period was associated with a significantly increased risk of having an episode in subsequent periods.
The researchers found that rates of suicide attempts were significantly higher in adolescents than in either the emerging adult or adult periods, which had similar rates. Among the participants who had a history of MDD through age 30, about 19% had at least one suicide attempt by the fourth time point.
MDD was associated with both anxiety and substance use disorders in all four developmental periods.
The researchers note that, to their knowledge, this is the first study to examine the markers of MDD across these four developmental periods.
Rohde and colleagues argue that this study makes an important contribution to our understanding of how depression emerges and develops over time because it provides critical information about the prevalence, duration, course, patterns of co-occurrence, and longer-term consequences of depression across four markedly diverse developmental periods.
Association for Psychological Science: http://www.psychologicalscience.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
A second child seems to have been cleared of the AIDS virus, thanks to heavy-duty drugs started just hours after birth. This spring researchers plan to test that approach in 60 more newborns.
A report finds that azodicarbonamide wasn't just in Subway's bread: It's in hundreds of foods. While it has been linked to asthma in factory workers, the additive poses no known risk to consumers.
Army initiative to research suicides in the US military released its first three studiesAmanda Holpuch
The luxury fibre can be fashioned into screws and plates that could hold broken bones together while they heal, before biodegrading when no longer needed
Middle-aged people on a high-protein diet are at greater risk of dying from cancer, claims a study, but critics say firm evidence is lacking
In an exclusive interview with National Geographic, Nora Volkow, director of the National Institute on Drug Abuse, shares her concerns about the consequences of legalizing the drug.
Tailor-made medical devices could give a more detailed picture of cardiac health and may be better at predicting and preventing problems.
People around the world are eating a wider range of foods. But as a whole, we are increasingly reliant on a few crops. Researchers say that increases the risk of agricultural disaster.
Mushrooms are being hailed as a miracle cure for cancer. But can a shiitake stir-fry really work wonders?
Elder care is a booming business, but someone has to pay. Seniors and their children shouldn't have to go bankrupt for care